Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3741. The usefulness of screening for mental illness. (PubMed)

The usefulness of screening for mental illness. The study assessed the effect of screening for mental disorder by means of the General Health Questionnaire (GHQ) on the rate of detection of mental disorder by fourteen physicians in a primary-care clinic. After completing the GHQ, patients were randomised into control (722 patients) and experimental (730 patients) groups. GHQ results of the experimental group were made available to the physicians; those of the control group were

1984 Lancet

3742. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. (PubMed)

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Since 1975 four rounds of screening with modern mammography for breast cancer have been carried out among 30 000 Nijmegen women born before 1940. The results up to the end of 1981 shows that the odds ratio of screened vs unscreened subjects among women who died from breast cancer compared with women who did not, was 0.48 (95% confidence interval 0.23-1.00

1984 Lancet

3743. Screening for subclinical osteomalacia in the elderly: normal ranges or pragmatism? (PubMed)

Screening for subclinical osteomalacia in the elderly: normal ranges or pragmatism? Although osteomalacia is known to be common in some sections of the elderly population, the disease is often subclinical and there is uncertainty about the point at which treatment is necessary. Identification and treatment of osteomalacia are inseparably bound; the response of varying degrees of subclinical disease to treatment with vitamin D or alfacalcidol is described here. The response is assessed

1983 Lancet

3744. Breast cancer screening and health service costs

Breast cancer screening and health service costs Breast cancer screening and health service costs Breast cancer screening and health service costs Gravelle H S, Simpson P R, Chamberlain J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Type (...) of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women over 40 years old. Setting The study was carried out in the United Kingdom. Dates to which data relate Price related to 1980. Source of effectiveness data Review of studies. Link between effectiveness and cost data Life years gained. Modelling Epidemiological cohort model (model of survival and disease). Direct costs Direct costs were to the health service and included screening, diagnosis, and treatment. Price

1982 NHS Economic Evaluation Database.

3745. The economics of screening for colo-rectal cancer

The economics of screening for colo-rectal cancer The economics of screening for colo-rectal cancer The economics of screening for colo-rectal cancer Kristein M M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening (...) and treatment of colorectal cancer. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Setting The study was carried out in the USA. Dates to which data relate Price relates to 1978. Source of effectiveness data Single study. Modelling Epidemiological cohort model (model of survival and disease). Measure of benefits used in the economic analysis Life-years gained. Direct costs Direct costs are to the health service and include: haemoccult screen, protosigmoidoscopy and/or air

1980 NHS Economic Evaluation Database.

3746. Multiphasic screening. Case-finding tool in a Teaching Hospital Medical Clinic. (PubMed)

Multiphasic screening. Case-finding tool in a Teaching Hospital Medical Clinic. Multiphasic screening as a case-finding tool was evaluated in a randomized, controlled study. For each of 112 physicians, a patient was assigned to one of three groups: multiphasic screening group (SG), chart abstract group (AG), or chart review group (RG). Medical problem lists constructed before and after receiving additional information were compared. Physicians for 36 SG patients identified considerably more new (...) medical problems, both total (77) and ones they considered important (25), than 40 AG physicians (14 and 8) and 36 RG physicians (4 and 0). One year later, 38 of the 95 newly identified problems had been acted on, 31 in the SG. Medical care was affected in nine patients: six in SG, two in AG, and one in RG. Multiphasic screening may help physicians identify new medical problems in clinic patients.

1977 JAMA

3747. Psychiatric screening in general practice. A controlled trial. (PubMed)

Psychiatric screening in general practice. A controlled trial. This study reports the efficacy of the General Health Questionnaire (G.H.Q.) in the secondary prevention of minor psychiatric illness in a primary-care setting. 1093 consecutive attenders at a general practitioner's surgery were screened for minor psychiatric disorder using the G.H.Q. 32% were found to have a conspicuous psychiatric disorder and a further 11% had a hidden psychiatric disorder. The group with hidden disorders were

1976 Lancet

3748. A controlled trial of multiphasic screening. (PubMed)

A controlled trial of multiphasic screening. A clinical controlled trial was designed to determine the impact of Automated Multiphasic Health Testing on morbidity and attitudes. Three strata comprising 574 families (lower-income group enrolled in health maintenance organization, lower-income not enrolled in such a project, and a middle-income group employed by a utility company) were interviewed to obtain information on utilization, morbidity, health status, and attitudes. Sixty percent (...) of adults in each stratum were then screened. All families were interviewed again one year later. The only significant difference found between screened and non-screened subjects was an increase in nights hospitalized for screened subjects. Physicians were interviewed to determine what abnormalities were found and what treatment was required for project and privately referred patients of these physicians. Previously unknown abnormalities prompted retesting for confirmation in only 28 per cent

1976 NEJM

3749. A long-term controlled trial of screening for hypertension in general practice. (PubMed)

A long-term controlled trial of screening for hypertension in general practice. A controlled trial was undertaken to evaluate the practical consequences of screening in general practice. Of 2420 people aged 40-64 years examined in 1967-68, 191 (7.9%) had previously been told, at some time, that they had raised blood-pressure, other than during pregnancy. However, only 77 (3-2%) had any record of current antihypertensive treatment. Screening resulted in a further 50 persons (2-1%) being newly (...) diagnosed as hypertensive in 1967-68 and a further 9 in 1969-70. Antihypertensive treatment was given to 21 of these immediately following diagnosis, while the treatment was adjusted in 23 of those already known to be hypertensive. In 1972-73 the blood-pressures of the screening population were directly compared with the control group. No significant differences in the distributions of their blood-pressure levels were observed. Over 95% of the new hypertensives discovered by the screening process

1976 Lancet

3750. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. (PubMed)

Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 5951878 1966 04 09 2016 10 17 0098-7484 195 9 1966 Feb 28 JAMA JAMA Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 731-8 Shapiro S S Strax P P Venet L L eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 AIM IM Adult Biopsy Breast Neoplasms diagnosis epidemiology Connecticut Female Follow-Up (...) Studies Humans Mammography Mass Screening Mastectomy Middle Aged Mortality New York Prognosis 1966 2 28 1966 2 28 0 1 1966 2 28 0 0 ppublish 5951878

1966 JAMA